The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 07, 2021

Filed:

Nov. 30, 2016
Applicant:

GE Healthcare As, Nydalen, NO;

Inventors:

Andreas Richard Meijer, Oslo, NO;

Mikkel Jacob Thaning, Oslo, NO;

Paritosh Jayant Dhawale, Brookfield, WI (US);

Salvatore Desena, Marlborough, MA (US);

Paul Alexander Jones, Buckinghamshire, GB;

Deirdre Cassidy, Buckinghamshire, GB;

Concetta Valeria Gringeri, Buckinghamshire, GB;

Assignee:

GE HEALTHCARE AS, Oslo, NO;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/10 (2006.01);
U.S. Cl.
CPC ...
A61K 49/105 (2013.01); A61K 49/101 (2013.01); A61K 49/108 (2013.01); A61K 2123/00 (2013.01);
Abstract

The present invention relates to in vivo imaging and in particular to magnetic resonance imaging (MRI). Provided by the present invention is a pharmaceutical formulation suitable for use in an MRI procedure and which offers advantages over known such formulations. A particular dose of the pharmaceutical formulation of the invention is also envisioned as well as the use of said dose in a method of in vivo imaging. This present invention provides for simultaneous administration of a liver specific agent and a second MR contrast agent that is capable of better/further enhancing the dynamic vascular phase in a patient. The method of the invention has the advantage of simplicity and patient comfort, compared to sequential injections. Furthermore, the method of the invention provides the advantage that it can enable a lower cumulative dose of contrast agents.


Find Patent Forward Citations

Loading…